drugset / Trial / NCT02469519

Impact of a Booster Course of Antenatal Steroids on Neonatal Outcome in Patients With Premature Rupture of the Membranes

NCT02469519

Phase 2/3 Completed 194 enrolled Pediatrix
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This trial hopes to prospectively evaluate the impact of one versus two courses of antenatal steroids on the incidence of major neonatal morbidity in pregnant women with pre-labor premature rupture of the membranes.

Timeline

Start
2016-03-03
Primary completion
2022-08-15
Completion
2022-10-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Betamethasone Other / unclassified 12 mg Intramuscular